Immunoglobulins for Intravenous Administration (IVIG)
Original notice title
Belgium – Immunoglobulins – Immunoglobulinen voor intraveneuze toediening (IVIG)
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Minimum turnover requirement is given as placeholder €XXX; actual amount may be high, potentially excluding bidders.
Inconsistency in EU funding flag: structured data indicates EU-funded, XML notice states 'no EU funds'. This could affe...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 12M estimated value
- Framework procurement
- Supplies contract
- 1 lot
- Duration 48 MONTH
- Supply of intravenous immunoglobulins (IVIG) on an as-needed basis under a single-operator framework agreement.
- Delivery to Sint-Niklaas, Belgium.
Show full summary
Open procedure framework agreement for the supply of intravenous immunoglobulins (IVIG) to VITAZ vzw in Sint-Niklaas, Belgium. Single lot, award based 100% on price, duration 48 months, maximum framework value €12,000,000 EUR. Essential tender documents available but not analyzed; key selection criterion (minimum average annual turnover) includes a placeholder (€XXX). Deadline 16 July 2026.
Risks
Minimum turnover requirement is given as placeholder €XXX; actual amount may be high, potentially excluding bidders.
Inconsistency in EU funding flag: structured data indicates EU-funded, XML notice states 'no EU funds'. This could affe...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Award criterion: price only (100% weight).
Eligibility
- Minimum average annual turnover over last 3 years – placeholder value (€XXX) to be specified.
Administrative
- Open procedure – electronic submission required.
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
Location
Sint-Niklaas, BEL
Website
Buyer profile
Identifier
0881.291.322
Activity
Health
Lots (1)
LOT-0001
Immunoglobulins for Intravenous Administration (IVIG)
Framework agreement for the supply of IVIG medicinal products on call-off basis over 48 months to VITAZ vzw in Sint-Niklaas.
EUR 12M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Kostprijs
Additional CPV codes
Value note
Framework maximum value
Show original TED data
Original lot title
Immunoglobulinen voor intraveneuze toediening (IVIG)
Original TED description
Deze opdracht betreft het afsluiten van een raamovereenkomst met één opdrachtnemer waarbij alle voorwaarden voor de uitvoering van deze opdracht worden vastgelegd. Het doel van de raamovereenkomst is de levering van geneesmiddelen door de opdrachtnemer op afroep van de aanbesteder gedurende de looptijd beschreven in het bestek. Voor verdere toelichting verwijzen wij naar de technische bepalingen van het bestek.
Procurement Details
- Publication date
- 21 Jun 2026
- Languages
- Dutch
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 424783-2026
Documents (2)
Similar tenders
Poland – Various medicinal products – Dostawa produktów leczniczych, nr PN-127/26/TM
Belgium – Various medicinal products – Leveren van paracetamol oplossing voor intraveneus gebruik voor de ziekenhuisapotheek
Belgium – Anaesthetics – LEVEREN VAN ROCURONIUM 50 MG/ 5 ML VOOR INTRAVENEUS GEBRUIK
France – Various medicinal products – FOURNITURE DE MEDICAMENTS RADIOPHARMACEUTIQUES (TEP et SCINTI) ______________________________________________________________________
Belgium – Medicinal products for the respiratory system – LEVEREN VAN PIRFENIDONE 267 mg en 801 mg (filmomhulde) tabletten
Norway – Medical equipments, pharmaceuticals and personal care products – 2801c Medicines infusion injection
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Minimum turnover requirement is given as placeholder €XXX; actual amount may be high, potentially excluding bidders.
Inconsistency in EU funding flag: structured data indicates EU-funded, XML notice states 'no EU funds'. This could affe...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications